See also this year's filing and all EDGAR filings for this company.
PDF Report 0001601485_2026_Elicio_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001601485, Elicio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 19,311,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 295,000 |
| 3 | remainder_Assets | 6,256,000 |
| 4 | LiabilitiesCurrent | 8,110,000 |
| 5 | LiabilitiesNoncurrent | 13,501,000 |
| 6 | remainder_Liabilities | 2,615,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,601,850 |
| 9 | ResearchAndDevelopmentExpense | 27,878,901 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -3,656,549 |
| 13 | remainder_ComprehensiveNetIncome | 42,174 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,862,000 |
| 1 | Liabilities | 24,226,000 |
| 2 | Expenses | 40,480,751 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,636,000 |
| 5 | NetIncome | -44,137,300 |
| 6 | ComprehensiveNetIncome | -44,116,213 |
| 7 | BaseVar | 47,133,737 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.62 |
| 9 | EconomicCapitalRatio | 1.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
